Search research articles
Contact Us
Filters
Showing results (81-90 of 95) with videos related to
Page
of 10
Sort By:
Plos One
|
April 18, 2013
Recombinant human growth hormone and rosiglitazone for abdominal fat accumulation in HIV-infected patients with insulin resistance: a randomized, double-blind, placebo-controlled, factorial trial
Marshall J Glesby, Jeanine Albu, Ya-Lin Chiu, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 4, 2007
The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo
Philip J Ellery, Emma Tippett, Ya-Lin Chiu, et al.
HIV Clinical Trials
|
April 15, 2016
Effect of Recombinant Human Growth Hormone and Rosiglitazone for HIV-Associated Abdominal Fat Accumulation on Adiponectin and other Markers of Inflammation
Vivien Leung, Ya-Lin Chiu, Donald P Kotler, et al.
Plos One
|
May 29, 2014
Dysregulated miR-361-5p/VEGF axis in the plasma and endothelial progenitor cells of patients with coronary artery disease
Hsei-Wei Wang, Hung-Hao Lo, Ya-Lin Chiu, et al.
Cancer Research
|
December 13, 2012
Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression
Pei-Chun Lin, Ya-Lin Chiu, Samprit Banerjee, et al.
Plos One
|
January 23, 2016
MicroRNA-134 Contributes to Glucose-Induced Endothelial Cell Dysfunction and This Effect Can Be Reversed by Far-Infrared Irradiation
Hsei-Wei Wang, Shu-Han Su, Yen-Li Wang, et al.
Journal of Vascular Research
|
January 26, 2017
Dysregulation of Vascular Endothelial Growth Factor Receptor-2 by Multiple miRNAs in Endothelial Colony-Forming Cells of Coronary Artery Disease
Shu-Han Su, Chun-Hsien Wu, Ya-Lin Chiu, et al.
Pathology, Research and Practice
|
July 31, 2025
SPINK1 immunohistochemistry: An ancillary tool to diagnose urothelial carcinoma in situ and urothelial dysplasia
Francesca Khani, Shaham Beg, Kyung Park, et al.
The Journal of Infectious Diseases
|
August 6, 2004
Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160
Deborah Lee, Barney S Graham, Ya-Lin Chiu, et al.
Clinical Transplants
|
August 7, 2014
Excellent outcomes with expanded criteria donor kidneys: the role of the recipient's age
David Serur, Sandip Kapur, Stuart Saal, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 95) with videos related to
Sort By:
Page
of 10
Plos One
|
April 18, 2013
Recombinant human growth hormone and rosiglitazone for abdominal fat accumulation in HIV-infected patients with insulin resistance: a randomized, double-blind, placebo-controlled, factorial trial
Marshall J Glesby, Jeanine Albu, Ya-Lin Chiu, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 4, 2007
The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo
Philip J Ellery, Emma Tippett, Ya-Lin Chiu, et al.
HIV Clinical Trials
|
April 15, 2016
Effect of Recombinant Human Growth Hormone and Rosiglitazone for HIV-Associated Abdominal Fat Accumulation on Adiponectin and other Markers of Inflammation
Vivien Leung, Ya-Lin Chiu, Donald P Kotler, et al.
Plos One
|
May 29, 2014
Dysregulated miR-361-5p/VEGF axis in the plasma and endothelial progenitor cells of patients with coronary artery disease
Hsei-Wei Wang, Hung-Hao Lo, Ya-Lin Chiu, et al.
Cancer Research
|
December 13, 2012
Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression
Pei-Chun Lin, Ya-Lin Chiu, Samprit Banerjee, et al.
Plos One
|
January 23, 2016
MicroRNA-134 Contributes to Glucose-Induced Endothelial Cell Dysfunction and This Effect Can Be Reversed by Far-Infrared Irradiation
Hsei-Wei Wang, Shu-Han Su, Yen-Li Wang, et al.
Journal of Vascular Research
|
January 26, 2017
Dysregulation of Vascular Endothelial Growth Factor Receptor-2 by Multiple miRNAs in Endothelial Colony-Forming Cells of Coronary Artery Disease
Shu-Han Su, Chun-Hsien Wu, Ya-Lin Chiu, et al.
Pathology, Research and Practice
|
July 31, 2025
SPINK1 immunohistochemistry: An ancillary tool to diagnose urothelial carcinoma in situ and urothelial dysplasia
Francesca Khani, Shaham Beg, Kyung Park, et al.
The Journal of Infectious Diseases
|
August 6, 2004
Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160
Deborah Lee, Barney S Graham, Ya-Lin Chiu, et al.
Clinical Transplants
|
August 7, 2014
Excellent outcomes with expanded criteria donor kidneys: the role of the recipient's age
David Serur, Sandip Kapur, Stuart Saal, et al.
Page
of 10